ThermoGenesis Announces Approval of AXP by India Ministry of Health
ThermoGenesis Corp. (NASDAQ: KOOL) said today that India's Ministry of Health has approved the AutoXpress® System, enabling the Company to initiate commercial sales of the product in India. The AXP is used for the processing of stem cells from cord blood.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.